10x genomics inc.

Precision-Instruments

TXG


Executive/
Director

Price

  • Last Close
  • $ 15.86
    $ +0.63 4.14 %
    Dec 6, 2024
  • 52-Week High/Low
  • $57.55 - $18.13
  • YTD
  • -71.7%

  • Trading Volume
  • 58,348
  • Market Cap Full
  • $ 1.8B
  • Shares Outstanding
  • 115.6M
    Mar 31, 2023
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Q1 - - - - - -5% 27.8% -49.3% 53.1% -32.9%
Q2 - - - - - 4% 8.2% -40.5% 0.1% -2.5%
Q3 - - - - -5.2% 8% -25.7% -37.1% -26.1% -
Q4 - - - - 52.1% 13.6% 3.1% 28% 38.2% -
J F M A M J J A S O N D
2024 -25.5% 11.9% -19.5% -3.8% - - - - - - - -
2023 28.5% 1.5% 17.4% -6% 0.1% 6.4% 12.8% -17.7% -20.4% -14.5% 23.4% 28.6%
    2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
    0%0%0%0%0%0%86%6%-76%54%-72%

Earnings

2015 2016 2017 2018 2019 2020 2021 2022 2023
Q1 - - - - - - -0.11 -0.38 -0.44
Q2 - - - - - - -0.1 -0.57 -0.53
Q3 - - - - 0.33 - -0.15 -0.37 -0.79
Q4 - - - - 0.07 - -0.17 -0.14 -
A 0 0 0 0 -0.8 -5.4 -0.5 -1.5 -1.76

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2019 2020 2021 2022 2023
Mar - 96.8 108.7 113 115.6
Jun - 99 109.9 113.6 -
Sep - 101.3 110.9 114.1 -
Dec 39.1 101.2 110.3 113.9 -

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 1.5 1.2 1.9 4.1 3.2
Fixed Asset Turnover 1.7 2.7 2.8 2 8.1
Total Asset Turnover 0.5 0.5 0.3 0.4 1.2
Leverage
Debt Ratio - - - - 0.2
Debt – Equity Ratio - - - 0.1 1.1
Interest Coverage 84 -8.7 -59.3 - -111
Equity multiplier 0.4 0.2 0.2 0.3 0.8